Virpax Pharmaceuticals Inc
OTC:VRPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virpax Pharmaceuticals Inc
OTC:VRPX
|
US |
|
Golden Flower Tbk PT
IDX:POLU
|
ID |
|
Chinlink International Holdings Ltd
HKEX:997
|
HK |
|
AmeriTrust Financial Technologies Inc
F:1ZV
|
CA |
|
O
|
Obzen Inc
KOSDAQ:417860
|
KR |
|
M
|
Mayfair Acquisition Corp
XTSX:MFA.P
|
CA |
|
Pembangunan Perumahan (Persero) Tbk PT
IDX:PTPP
|
ID |
|
Podium Minerals Ltd
F:55D
|
AU |
|
Augusta Gold Corp
TSX:G
|
CA |
|
CTW Cayman
NASDAQ:CTW
|
JP |
|
Trans Power Marine Tbk PT
IDX:TPMA
|
ID |
|
J
|
Joy City Corp
KOSDAQ:067000
|
KR |
|
S
|
Seegnal Inc
XTSX:SEGN
|
CA |
|
A
|
Affimed NV
F:A28
|
DE |
|
E
|
EEMS Italia SpA
F:E2Y
|
IT |
|
St Joseph Inc
OTC:STJO
|
US |
|
M
|
Mediana Co Ltd
KOSDAQ:041920
|
KR |
Bankruptcy Probability
Virpax Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virpax Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Virpax Pharmaceuticals Inc
NASDAQ:VRPX
|
256 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
368B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
297.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virpax Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virpax Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
